249
Views
36
CrossRef citations to date
0
Altmetric
Review

The potential therapeutic use of phosphodiesterase 10 inhibitors

, &
Pages 147-158 | Published online: 31 Jan 2007

Bibliography

  • FUJISHIGE K, KOTERA J, MICHIBATA H et al.: Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A). J. Biol. Chem. (1999) 274:18438-18445.
  • LOUGHNEY K, SNYDER PB, UHER L, ROSMAN GJ, FERGUSON K, FLORIO VA: Isolation and characterization of PDE10A, a novel human 3′, 5′-cyclic nucleotide phosphodiesterase. Gene (1999) 234:109-117.
  • SODERLING SH, BAYUGA SJ, BEAVO JA: Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. Proc. Natl Acad. Sci. USA (1999) 96:7071-7076.
  • FUJISHIGE K, KOTERA J, OMORI K: Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A. Eur. J. Biochem. (1999) 266:1118-1127.
  • COSKRAN TM, MORTON D, MENNITI FS et al.: Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species. J. Histochem Cytochem. (2006) 54:1205-1213.
  • SEEGER TF, BARTLETT B, COSKRAN TM et al.: Immunohistochemical localization of PDE10A in the rat brain. Brain Res. (2003) 985:113-126.
  • KOTERA J, SASAKI T, KOBAYASHI T, FUJISHIGE K, YAMASHITA Y, OMORI K: Subcellular localization of cyclic nucleotide phosphodiesterase type 10A. J. Biol. Chem. (2004) 279:4366-4375.
  • XU RX, HASSELL AM, VANDERWALL D et al.: Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity. Science (2000) 288:1822-1825.
  • CARD GL, ENGLAND BP, SUZUKI Y et al.: Structural basis for the activity of drugs that inhibit phosphodiesterases. Structure (2004) 12:2233-2247.
  • MANALLACK DT, HUGHES RA, THOMPSON PE: The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases. J. Med. Chem. (2005) 48:3449-3462.
  • SUNG BJ, YEON HK, HO JY et al.: Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules. Nature (2003) 425:98-102.
  • FUJISHIGE K, KOTERA J, YUASA K et al.: The human phosphodiesterase PDE10A gene. Eur. J. Biochem. (2000) 267:5943-5951.
  • KOTERA J, FUJISHIGE K, YUASA K et al.: Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP. Biochem. Biophys. Res. Commun. (1999) 261:551-557.
  • GROSS-LANGENHOFF M, HOFBAUER K, WEBER J et al.: cAMP is a ligand for the tandem gaf domain of human phosphodiesterase 10 and cGMP for the tandem GAF domain of phosphodiesterase 11. J. Biol. Chem. (2006) 281:2841-2846.
  • XIE Z, ADAMOWICZ WO, ELDRED WD et al.: Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase. Neuroscience (2006) 139:597-607.
  • SIUCIAK JA, CHAPIN DS, HARMS JF, LEBEL LA, McCARTHY SA, CHAMBERS L: Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis. Neuropharmacology (2006) 51:386-396.
  • SIUCIAK JA, McCARTHY SA, CHAPIN DS et al.: Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function. Neuropharmacology (2006) 51:374-385.
  • RODEFER JS, MURPHY ER, BAXTER MG: PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats. Eur. J. Neuroscience (2005) 21:1070-1076.
  • HUANG Z, LIU S, ZHANG L et al.: Preferential inhibition of human phosphodiesterase 4 by ibudilast. Life Sci. (2006) 78:2663-2668.
  • GIBSON LCD, HASTINGS SF, MCPHEE I et al.: The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family. Eur. J. Pharmacol. (2006) 538:39-42.
  • MENNITI FS, FARACI WS, SCHMIDT CJ: Phosphodiesterases in the CNS: targets for drug development Nat. Drug Disc. Rev. (2006) 5:660-670.

Patents

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.